N8 Medical Submits IDE for Breakthrough CeraShield(TM) Endotracheal Tube Device
Plans to Initiate First-in-Human testing in First Quarter of 2018 DUBLIN, Ohio, Feb. 8, 2018 -- (Healthcare Sales & Marketing Network) -- N8 Medical, LLC today announced the submission of its Investigational Device Exemption (IDE) for its flagship Cera... Devices, FDA N8 Medical, CeraShield, Endotracheal Tube, ceragenins (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 8, 2018 Category: Pharmaceuticals Source Type: news

Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
PLAINSBORO, N.J., Feb. 8, 2018 -- (Healthcare Sales & Marketing Network) -- Novo Nordisk, a global healthcare company, today announced that Rebinyn®, Coagulation Factor IX (Recombinant), GlycoPEGylated, is now available in the United States for the tr... Biopharmaceuticals, Product Launch Novo Nordisk, Rebinyn, Coagulation Factor IX, Hemophilia B (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 8, 2018 Category: Pharmaceuticals Source Type: news

ZYTIGA(R) (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer
New indication for ZYTIGA® in combination with prednisone provides treatment option for patients with metastatic high-risk castration-sensitive prostate cancer Findings from pivotal Phase 3 LATITUDE clinical trial data demonstrated statistically sig... Biopharmaceuticals, Oncology, FDA Janssen Pharmaceutical, ZYTIGA, abiraterone, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 8, 2018 Category: Pharmaceuticals Source Type: news

BioStrata unveils expanded leadership team
Life science marketing agency celebrates promotions underpinned by ongoing growth CAMBRIDGE, UK – Feb 7, 2018 -- (Healthcare Sales & Marketing Network) -- BioStrata, a specialist life science marketing agency, has today announced senior promotions to tw... Biopharmaceuticals, Personnel BioStrata (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2018 Category: Pharmaceuticals Source Type: news

closerlook, inc. names Steve Tulk as Chief Technology Officer
Chicago, Ill., February 7, 2018 -- (Healthcare Sales & Marketing Network) -- As pharmaceutical companies continue to adopt emerging technologies to support and enhance their sales and marketing initiatives, they are increasingly dependent on their agency p... Biopharmaceuticals, Personnel closerlook (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2018 Category: Pharmaceuticals Source Type: news

Abbott's App for FreeStyle(R) Libre System Now Available in Europe for Both iPhone and Android
FREESTYLE LIBRELINK[1],[2] APP ENABLES FREESTYLE LIBRE USERS TO MONITOR THEIR GLUCOSE DIRECTLY WITH THEIR SMARTPHONE ABBOTT PARK, Ill., Feb. 7, 2018 -- (Healthcare Sales & Marketing Network) -- Abbott (NYSE: ABT) announced today the FreeStyle LibreLink... Devices, Monitoring, Endocrinology, Product Launch Abbott, FreeStyle Libre, blood glucose (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2018 Category: Pharmaceuticals Source Type: news

UNITY Biotechnology Adds Accomplished RandD Leader David L. Lacey, M.D., to Board of Directors
SAN FRANCISCO, Feb. 7, 2018 -- (Healthcare Sales & Marketing Network) -- UNITY Biotechnology, Inc. ("UNITY"), a privately held biotechnology company developing therapeutics that prevent, halt, or reverse numerous diseases of aging, today announc... Biopharmaceuticals, Personnel UNITY Biotechnology, senolytic medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2018 Category: Pharmaceuticals Source Type: news

Gore to Debut GORE(TM) ImproJect(TM) Plunger for Sensitive Biologics in Pre-Filled Syringes
NEWARK, Del., Feb. 6, 2018 -- (Healthcare Sales & Marketing Network) -- W.L. Gore & Associates, Inc. ("Gore"), a global materials science company, will introduce its new GORE™ ImproJect™ Plunger at Pharmapack 2018, Europe's dedicated pharmaceuti... Devices, Drug Delivery, Product Launch W.L. Gore, ImproJect, Pre-Filled Syringe (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2018 Category: Pharmaceuticals Source Type: news

Grifols HyperRAB(R) (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection
Innovative new formulation delivers higher concentration of anti-rabies virus antibodies per mL at wound site compared to other rabies immune globulin products on the market Reduced volume of medication offers potential for fewer injections for patients... Biopharmaceuticals, FDA Grifols, HyperRAB, rabies immune globulin, Rabies Virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2018 Category: Pharmaceuticals Source Type: news

7D Surgical Completes Significant Round of Financing
Investment to fund commercialization and development of the game changing Machine-vision Image Guided Surgery (MvIGS) technology TORONTO, Feb. 6, 2018 -- (Healthcare Sales & Marketing Network) -- 7D Surgical is pleased to announce the completion of the... Devices, Surgery, Venture Capital 7D Surgical, MvIGS, Machine-vision, Image Guided Surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2018 Category: Pharmaceuticals Source Type: news

Varian Halcyon Treatment System Receives AERB Certificate for Import and Supply in India
PALO ALTO, Calif. and MUMBAI, India, Feb. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced the Halcyon™ cancer treatment platform has received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply i... Devices, Oncology, Regulatory Varian Medical Systems, Halcyon, IMRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2018 Category: Pharmaceuticals Source Type: news

eNeura, Inc. Announces Series D Financing
Investment to fund commercialization of eNeura's sTMS mini for treatment and prevention of migraine BALTIMORE, Feb. 6, 2018 -- (Healthcare Sales & Marketing Network) -- eNeura, Inc., a privately held medical technology company developing non-invasive, ... Devices, Neurology, Venture Capital eNeura Inc, mini neuromodulation, SpringTMS, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2018 Category: Pharmaceuticals Source Type: news

New Study Finds truFreeze(R) Spray Cryotherapy Less Painful than Radiofrequency Ablation for Treatment of Barrett's Esophagus Related Diseases
LEXINGTON, Mass., Feb. 6, 2018 -- (Healthcare Sales & Marketing Network) -- CSA Medical is pleased to announce that in a multi-center prospective study conducted at three leading academic centers published in the Journal of Clinical Gastroenterology (Liqu... Devices, Gastroenterology CSA Medical, truFreeze, Barrett's Esophagus, cryotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2018 Category: Pharmaceuticals Source Type: news

FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials
ORC-13661 Could be the First Medicine Approved Specifically to Prevent Hearing Loss of Patients Using Certain Antibiotics SEATTLE, Feb. 5, 2018 -- (Healthcare Sales & Marketing Network) -- ORICULA THERAPEUTICS, LLC., a biotech company introducing medic... Biopharmaceuticals, FDA Oricula Therapeutics, ORC-13661, hearing loss (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2018 Category: Pharmaceuticals Source Type: news

Trethera Corporation Announces FDA Clearance of Investigational New Drug Application for TRE-515
LOS ANGELES, Feb. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Trethera Corporation, a biopharmaceutical company committed to developing novel drugs targeting cellular nucleotide metabolism for the treatment of cancer, today announced that the U.S... Biopharmaceuticals, Oncology, FDA Trethera, TRE-515, deoxycytidine kinase, myelodysplastic syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2018 Category: Pharmaceuticals Source Type: news

Varian Acquires Mobius Medical Systems
Company expands Quality Assurance tool portfolio PALO ALTO, Calif., Feb. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it has acquired privately-held Mobius Medical Systems®, a leader in radiation oncology ... Devices, Oncology, Mergers & Acquisitions Varian Medical Systems, Mobius Medical Systems, Mobius3D, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2018 Category: Pharmaceuticals Source Type: news

Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta(R)
BRIDGEWATER, N.J., Feb. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP (CII) in 18, 27, 36, and 54 mg strengths. Amneal's methylphenidate is an AB-rat... Biopharmaceuticals, Generics, Product Launch Amneal Pharmaceuticals, methylphenidate, Concerta (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2018 Category: Pharmaceuticals Source Type: news

Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nasopharyngeal Cancer Immunotherapy Trial
With the Stanford Cancer Institute joining as a clinical trial partner, Tessa's Phase III trial for nose cancer (nasopharyngeal cancer) is now widely accessible across multiple locations in the U.S. The therapy is based on Tessa's Virus-Specific T cell ... Biopharmaceuticals, Oncology Tessa Therapeutics, nasopharyngeal cancer, T cell immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2018 Category: Pharmaceuticals Source Type: news

BrainStorm Cell Therapeutics Appoints Senior Kite Executive, Anthony Polverino, Ph.D., to Board of Directors
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Feb. 5, 2018 -- (Healthcare Sales & Marketing Network) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today the... Biopharmaceuticals, Neurology, Personnel BrainStorm Cell Therapeutics, NurOwn , stem cell, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2018 Category: Pharmaceuticals Source Type: news

Appointment of Jonathan E. Gold as Interim Chief Financial Officer
NEW YORK, Feb. 02, 2018 -- (Healthcare Sales & Marketing Network) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB) ("Motif Bio" or the "Company"), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today a... Biopharmaceuticals, Personnel Motif Bio, multi-drug resistant bacteria, MRSA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 2, 2018 Category: Pharmaceuticals Source Type: news

Cardinal Health Announces Closing of Cardinal Health China Distribution Business Divestiture to Shanghai Pharma
DUBLIN, Ohio, Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Cardinal Health (NYSE: CAH) today announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharma&q... Biopharmaceuticals, Devices, Acquisitions Cardinal Health, Shanghai Pharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 2, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves AVYCAZ(R) (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
First Gram-Negative Antibiotic Approved in the U.S. to Treat HABP/VABP in Over 15 Years DUBLIN, Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the U.S. F... Biopharmaceuticals, FDA Allergan, AVYCAZ, ceftazidime, avibactam, Bacterial Pneumonia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 2, 2018 Category: Pharmaceuticals Source Type: news

Zynex introduces the NeuroMove(TM) Device to its expanding sales force
LONE TREE, Colo., Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilita... Devices, Product Launch Zynex, electrotherapy, NeuroMove (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2018 Category: Pharmaceuticals Source Type: news

Mark Casey Joins Mallinckrodt as General Counsel
Brings expertise in intellectual property, regulatory and legal strategy STAINES-UPON-THAMES, United Kingdom, Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, tod... Biopharmaceuticals, Personnel Mallinckrodt (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2018 Category: Pharmaceuticals Source Type: news

Amneal Introduces Isotretinoin Capsules, USP
BRIDGEWATER, N.J., Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals has launched isotretinoin capsules, USP, an AB-rated generic for Accutane® in 10 mg, 20 mg, 30 mg and 40 mg strengths. The product is available in cart... Biopharmaceuticals, Dermatology, Generics, Product Launch Amneal Pharmaceuticals, isotretinoin, Accutane (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2018 Category: Pharmaceuticals Source Type: news

Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva(R) Tablets
Launch further strengthens Mylan's leading antiretroviral portfolio Mylan is eligible for 180 days of exclusivity HERTFORDSHIRE, England and PITTSBURGH, Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Global pharmaceutical leader Mylan N.V... Biopharmaceuticals, HIV/AIDS, Generics, Product Launch Mylan, Efavirenz, Sustiva (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2018 Category: Pharmaceuticals Source Type: news

Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer(TM) Procedure for Treatment of Refractory Angina
Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure VANCOUVER, Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a l... Devices, Interventional, Cardiology, Reimbursement Neovasc , Reducer, angina pectoris, refractory angina (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2018 Category: Pharmaceuticals Source Type: news

Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory Angina
Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure VANCOUVER, Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a l... Devices, Interventional Cardiology, Reimbursement Neovasc, Reducer, angina pectoris, refractory angina (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2018 Category: Pharmaceuticals Source Type: news

Partner Therapeutics, Inc. (PTx) Closes $60 Million Financing
Funds to support pipeline development and commercial operations BOSTON, Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Partner Therapeutics, Inc. (PTx) announced today the closing of a Series A financing to support the launch and growth of t... Biopharmaceuticals, Venture Capital Partner Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2018 Category: Pharmaceuticals Source Type: news

Partner Therapeutics (PTx) Acquires Leukine(R) from Sanofi
Purchase includes Lynnwood, WA Biologics Manufacturing Facility BOSTON, Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Boston-based cancer company Partner Therapeutics, Inc. (PTx) announced today that it has acquired the global rights to dev... Biopharmaceuticals, Acquisitions Partner Therapeutics, Sanofi, Leukine, sargramostim (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2018 Category: Pharmaceuticals Source Type: news

Grünenthal Group Receives FDA's Expedited Access Pathway Designation for VIVO
AACHEN, Germany, February 1, 2018 -- (Healthcare Sales & Marketing Network) -- Grünenthal announced today that Adhesys Medical Inc., a wholly-owned subsidiary of Grünenthal, has been granted Expedited Access Pathway (EAP) designation by the U.S.... Devices Grünenthal Group, Adhesys Medical, VIVO , Flix , surgical sealant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2018 Category: Pharmaceuticals Source Type: news

Boehringer Ingelheim Announces Paul Fonteyne to Retire at the end of 2018. Wolfgang Baiker Appointed U.S. President and CEO Effective March 1, 2018
RIDGEFIELD, Conn., Jan. 31, 2018 -- (Healthcare Sales & Marketing Network) -- Boehringer Ingelheim announced today that Paul Fonteyne, U.S. President and CEO will retire after 15 years of committed service on December 31, 2018. Wolfgang Baiker, M.D, Ph.D,... Biopharmaceuticals, Personnel Boehringer Ingelheim (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2018 Category: Pharmaceuticals Source Type: news

INSIGHTEC Closes $150 Million Series E Financing
HAIFA, Israel and MIAMI, January 31, 2018 -- (Healthcare Sales & Marketing Network) -- INSIGHTEC®, a commercial-stage medical technology company revolutionizing surgery with incisionless MRI-guided focused ultrasound (MRgFUS) announced today the closi... Devices, Venture Capital INSIGHTEC, MRgFUS, Exablate Neuro, essential tremor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2018 Category: Pharmaceuticals Source Type: news

Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
Industry Veteran brings over 30 years of experience in drug development JERUSALEM, Jan. 31, 2018 -- (Healthcare Sales & Marketing Network) -- Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical stage biopharmaceutical company focused on developi... Biopharmaceuticals, Drug Delivery, Personnel Intec Pharma, Accordion Pill (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2018 Category: Pharmaceuticals Source Type: news

Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics and Artificial Intelligence
San Francisco- and Singapore-based biotech company raises $10 million in seed round from leading American and Asian investors; round was co-led by DHVC (Danhua Capital) and 6 Dimensions Capital, with participation from WuXi Apptec, EDBI, Pavilion Capital, ... Biopharmaceuticals, Venture Capital Engine Biosciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2018 Category: Pharmaceuticals Source Type: news

The Ottawa Hospital Acquires Several Elekta Versa HD Devices for Advanced Cancer Treatment
Innovative cancer treatment advancements on horizon for Ottawa patients STOCKHOLM, Jan. 31, 2018 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) announced today that it has signed a strategic agreement with The Ottawa Hospital (TOH) in ... Devices, Oncology Elekta, Versa HD, linear accelerator, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2018 Category: Pharmaceuticals Source Type: news

Varian Signs Agreement to Acquire Sirtex
Acquisition to expand Varian's cancer care portfolio PALO ALTO, Calif., Jan. 30, 2018 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems VAR, -0.77% today announced it has signed an agreement to acquire all the outstanding shares of Si... Devices, Oncology, Mergers & Acquisitions Varian Medical Systems, Sirtex Medical, SIR-Spheres, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2018 Category: Pharmaceuticals Source Type: news

FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly
SAN DIEGO, Jan. 30, 2018 -- (Healthcare Sales & Marketing Network) -- Dauntless Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of specialty therapeutics announces that the U.S. Food and Drug Administration (FD... Biopharmaceuticals, FDA Dauntless Pharmaceuticals, acromegaly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2018 Category: Pharmaceuticals Source Type: news

Bracco Diagnostics Inc. receives U.S. Food and Drug Administration (FDA) approval for use of MultiHance(R) (gadobenate dimeglumine) injection in magnetic resonance imaging of the central nervous system in pediatric patients younger than two years of age
MONROE TOWNSHIP, N.J., Jan. 30, 2018 -- (Healthcare Sales & Marketing Network) -- Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world's leading companies in the diagnostic imaging business, announced today that the labe... Biopharmaceuticals, Devices, Diagnostics, Radiology, FDA Bracco Diagnostics, MultiHance, gadobenate dimeglumine, magnetic resonance (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2018 Category: Pharmaceuticals Source Type: news

BridgeBio Pharma Licenses Late-Stage Oncology Drug Infigratinib to Tackle FGFR-Driven Maladies; Establishes New Subsidiary QED Therapeutics with $65 Million in Initial Financing
PALO ALTO, Calif., Jan. 30, 2018 -- (Healthcare Sales & Marketing Network) -- BridgeBio Pharma today announced that it is has licensed infigratinib (BGJ398), a highly potent and selective inhibitor of the tyrosine kinase receptor FGFR, from Novartis. In a... Biopharmaceuticals, Oncology, Licensing BridgeBio Pharma, QED Therapeutics, infigratinib, Novartis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2018 Category: Pharmaceuticals Source Type: news

Meso Scale Diagnostics Receives First FDA Clearance for IVD Assay
ROCKVILLE, Md., Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- Meso Scale Diagnostics, LLC. (MSD) is pleased to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its conventional C-reactive pro... Diagnostics, Personalized Medicine, FDA Meso Scale Diagnostics, C-reactive protein (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2018 Category: Pharmaceuticals Source Type: news

gammaCore(R) Receives FDA Clearance for the Acute Treatment of Pain Associated with Migraine Headache in Adult Patients
First non-invasive vagus nerve stimulation therapy applied at the neck provides new option for Americans living with migraine BASKING RIDGE, N.J., Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- electroCore, LLC (electroCore), a commercial-s... Devices, Neurology, FDA gammaCore, vagus nerve, neuromodulation, migraine, cluster headache (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2018 Category: Pharmaceuticals Source Type: news

Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
FDA Assigns PDUFA Target Action Date of November 13, 2018 DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Myla... Biopharmaceuticals, FDA Theravance Biopharma, Mylan, Revefenacin, COPD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2018 Category: Pharmaceuticals Source Type: news

Bioness Receives Health Canada Approval for StimRouter Neuromodulation System
Device for chronic pain management now approved to market in Canada VALENCIA, Calif., Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- Bioness, Inc., the leading provider of cutting edge, clinically supported rehabilitation therapies, today a... Devices, Neurology, Regulatory Bioness, StimRouter, Neuromodulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2018 Category: Pharmaceuticals Source Type: news

Mardil Medical Appoints Martin Madden to Board of Directors
Addition prepares medical device company for next stage of growth MINNEAPOLIS, Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- Mardil Medical Inc., a privately held, clinical-stage medical device company, announced the appointment of Martin ... Devices, Cardiology, Personnel Mardil Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2018 Category: Pharmaceuticals Source Type: news

Study Shows CyberKnife(R) System Provides Long-Lasting Pain Relief for Trigeminal Neuralgia Patients
CyberKnife Frameless Radiosurgery Offers a Precise and Non-Invasive Technique with Clinical Outcomes Similar to Gamma Knife Frame-Based Invasive Radiosurgery SUNNYVALE, Calif., Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- Accuray Incorpor... Devices, Neurosurgery, Neurology Accuray, CyberKnife, trigeminal neuralgia, radiosurgery, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2018 Category: Pharmaceuticals Source Type: news

Bionik Laboratories Corp. Appoints Andre Auberton-Herve as Chairman of Board of Directors
Auberton-Herve brings substantial leadership experience within strategic, operational, and financial activities to new role with Bionik board TORONTO and BOSTON, Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- Bionik Laboratories Corp. (OTCQ... Devices, Personnel Bionik Laboratories (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2018 Category: Pharmaceuticals Source Type: news

Paradigm Spine Announces Landmark Publication Of coflex(R) Vs. Decompression Alone In The Journal Of Neurosurgery Spine
2-year Study Results Demonstrate Decompression with coflex® Interlaminar Stabilization extends durability and sustainability of a decompression procedure The study authors concluded that decompression with coflex Interlaminar Stabilization extends t... Devices, Neurosurgery, Orthopaedic Paradigm Spine, coflex, spinal stenosis, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2018 Category: Pharmaceuticals Source Type: news

MedyMatch Receives Expedited Access Pathway / Breakthrough Device Designation from the FDA to Accelerate Market Access for Intracranial Hemorrhage Software
TEL AVIV, Israel, Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- MedyMatch Technology, a company focused on helping physicians provide accurate patient assessment through artificial intelligence (AI)-based insights, today announced that it has... Devices, Radiology, Neurosurgery, FDA MedyMatch Technology, intracranial hemorrhage (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2018 Category: Pharmaceuticals Source Type: news

SyntheticMR AB - Segmentation and Quantification of Brain Tissue, and Industry First Myelin Volume Measurements in SyMRI now FDA Cleared
The new regulatory clearance from the American Food and Drug Administration, FDA, concerns the SyMRI NEURO product package. Combined with FDA's clearance from August 2017, this means SyMRI as a whole can now be offered to clinics and hospitals on the US ma... Devices, Radiology, Neurology, FDA SyntheticMR, SyMRI NEURO, quantitative MR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2018 Category: Pharmaceuticals Source Type: news